Magnesium replacement improves the metabolic profile in obese and pre-diabetic patients with mild-to-moderate chronic kidney disease: A 3-month, randomised, double-blind, placebo-controlled study

Kidney and Blood Pressure Research

Volumn 42, Issue 1, 2017, Pages 33-42

  Toprak, Omer ^a   Kurt, Huseyin ^b   Sarl, Yasin ^b   Şarklş, Cihat ^a   Us, Halil ^b   Klrlk, Ali ^b  

^a BALIKESIR UNIVERSITY   (Turkey)

^b Department of Medicine   (Turkey)

Author keywords

Chronic kidney disease; Hypomagnesemia; Insulin resistance; Obesity; Pre diabetes

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; INSULIN; MAGNESIUM; PLACEBO; URIC ACID;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOMAGNESEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; WAIST CIRCUMFERENCE; AGED; COMPLICATION; DIETARY SUPPLEMENT; MAGNESIUM DEFICIENCY; METABOLOME; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; METABOLOME; MIDDLE AGED; OBESITY; PREDIABETIC STATE; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85015659226     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000468530     Document Type: Article

References (51)

1. Gröber U, Schmidt J, Kisters K: Magnesium in Prevention and Therapy. Nutrients 2015;7: 8199-8226. 10.3390/nu7095388 26404370
2. Geiger H, Wanner C: Magnesium in disease. Clin Kidney J 2012;5:i25-i38. 10.1093/ndtplus/sfr165 26069818
3. Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F: A systematic review and meta-Analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 2016;111: 272-282. 10.1016/j.phrs.2016.06.019 27329332
4. Floege J: Magnesium in CKD: more than a calcification inhibitor? J Nephrol 2015;28: 269-277. 10.1007/s40620-014-0140-6 25227765
5. Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Selvin E, Coresh J, Kao WH: Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int 2015;87: 820-827. 10.1038/ki.2014.331 25272232
6. Hruby A, Meigs JB, O'Donnell CJ, Jacques PF, McKeown NM: Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-Aged americans. Diabetes Care 2014;37: 419-427. 10.2337/dc13-1397 24089547
7. Plantinga LC, Crews DC, Coresh J, Miller ER Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team: Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 2010;5: 673-682. 10.2215/CJN.07891109 20338960
8. Grundy SM: Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012;59: 635-643. 10.1016/j.jacc.2011.08.080 22322078
9. Van Laecke S, Nagler EV, Verbeke F, Van Biesen W, Vanholder R: Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med 2013;126: 825-831. 10.1016/j.amjmed.2013.02.036 23891286
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419. 10.1007/BF00280883 3899825
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604-612. 10.7326/0003-4819-150-9-200905050-00006 19414839
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2 14656957
13. Thomas L: Clinical laboratory diagnostics: Use and assessment of clinical laboratory results. TH-Books Verlagsgesellschaft. Frankfurt, 1998, pp. 231-241.
14. Ali AA, Bakr RM, Yousif M, Foad RE: Assessment of serum magnesium level in patients with bronchial asthma. Egypt J Chest Dis Tuberc 2015;64: 535-539. 10.1016/j.ejcdt.2015.04.010
15. Rodríguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014;45: 388-393. 10.1016/j.arcmed.2014.05.003 24830937
16. Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L: Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 2009;205: 290-295. 10.1016/j.atherosclerosis.2008.11.028 19135196
17. Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN; IRIS Trial Investigators: Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease. Diabetes Care 2016;39: 1684-1692. 10.2337/dc16-0798 27465265
18. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81-S90. 10.2337/dc10-S062 20042775
19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): JAMA 2001;285: 2486-2497. 10.1001/jama.285.19.2486 11368702
20. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266. 11904577
21. Bertinato J, Wu Xiao C, Ratnayake WM, Fernandez L, Lavergne C, Wood C, Swist E: Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men. Food Nutr Res 2015;5;59: 25974. 10.3402/fnr.v59.25974 25947295
22. Simmons D, Joshi S, Shaw J: Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010;87: 261-266. 10.1016/j.diabres.2009.11.003 20004036
23. Rodriguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26: 1147-1152. 10.2337/diacare.26.4.1147 12663588
24. Lacson E Jr, Wang W, Ma L, Passlick-Deetjen J: Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis 2015;66: 1056-1066. 10.1053/j.ajkd.2015.06.014 26190226
25. Li L, Streja E, Rhee CM, Mehrotra R, Soohoo M, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K: Hypomagnesemia and mortality in incident hemodialysis patients. Am J Kidney Dis 2015;66: 1047-1055. 10.1053/j.ajkd.2015.05.024 26184377
26. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y: Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 2014;85: 174-181. 10.1038/ki.2013.327 23986148
27. Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N: Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008;38: 389-396. 10.1111/j.1365-2362.2008.01957.x 18489400
28. Guerrero-Romero F, Flores-García A, Saldaña-Guerrero S, Simental-Mendía LE, Rodríguez-Morán M: Obesity and hypomagnesemia. Eur J Intern Med 2016;34: 29-33. 10.1016/j.ejim.2016.06.015 27353277
29. Šafránek R, Moučka P, Vávrová J, Palička V, Pavlíková L, Sulková SD: Changes of serum calcium, magnesium and parathyroid hormone induced by hemodialysis with citrate-enriched dialysis solution. Kidney Blood Press Res 2015;40: 13-21. 10.1159/000368478 25661822
30. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M: Oral magnesium supplementation improves insülin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes. Metab 2004;30:253-258. 10.1016/S1262-3636(07)70116-7 15223977
31. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A: Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects-A double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011;13: 281-284. 10.1111/j.1463-1326.2010.01332.x 21205110
32. Guerrero-Romero F, Simental-Mendía LE, Hernández-Ronquillo G, Rodriguez-Morán M: Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: a double-blind placebo-controlled randomized trial. Diabetes Metab 2015;41: 202-207. 10.1016/j.diabet.2015.03.010 25937055
33. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014;45: 325-330. 10.1016/j.arcmed.2014.04.006 24814039
34. Simental-Mendía LE, Rodríguez-Morán M, Reyes-Romero MA, Guerrero-Romero F: No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study. Magnes Res 2012;25: 140-146. 10.1684/mrh.2012.0322 23073360
35. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M: Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 2014;28: 67. eCollection 2014. 25405132
36. Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F, Cordova-Uscanga R, Juárez-Rojop IE, Aguilar-Mariscal H, Tovilla-Zarate CA, Lopez-Guevara Mdel R: No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnes Res 2014;27: 48-56. 10.1684/mrh.2014.0361 25204013
37. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, Butch A, Liu S: Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011;93: 463-473. 10.3945/ajcn.110.002949 21159786
38. Guerrero-Romero F, Rodriguez-Moran M: Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39: 209-213. 10.1007/s005920200036 12486495
39. Lima de Souza E Silva Mde L, Cruz T, Rodrigues LE, Ladeia AM, Bomfim O, Olivieri L, Melo J, Correia R, Porto M, Cedro A: Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. J Clin Med Res 2014;6: 456-462. 10.14740/jocmr1580w 25247020
40. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A, Zebekakis PE, Pikilidou MI, Lasaridis AN: Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010;16:CR307-312. 20531272
41. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr, He K: Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010;33: 2604-2610. 10.2337/dc10-0994 20807870
42. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S: Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010;33: 304-310. 10.2337/dc09-1402 19903755
43. Li C, Hsieh MC, Chang SJ: Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 2013;25: 210-216. 10.1097/BOR.0b013e32835d951e 23370374
44. Liu ZM, Ho SC: The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas 2011;70: 176-181. 10.1016/j.maturitas.2011.07.007 21821372
45. Sakaguchi Y, Shoji T, Hayashi T, Suzuki A, Shimizu M, Mitsumoto K, Kawabata H, Niihata K, Okada N, Isaka Y, Rakugi H, Tsubakihara Y: Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care 2012;35: 1591-1597. 10.2337/dc12-0226 22498805
46. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, Yanagawa N, Pham PT: Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol 2005;63: 429-436. 10.5414/CNP63429 15960144
47. Holzmacher R, Kendziorski C, Michael Hofman R, Jaffery J, Becker B, Djamali A: Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Nephrol Dial Transplant 2005;20: 1456-1462. 10.1093/ndt/gfh831 15840674
48. Van Laecke S, Nagler EV, Taes Y, Van Biesen W, Peeters P, Vanholder R: The effect of magnesium supplements on early post-Transplantation glucose metabolism: a randomized controlled trial. Transpl Int 2014;27: 895-902. 10.1111/tri.12287 24909487
49. Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A: Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol 2013;69: 309-316. 10.1159/000346427 23548855
50. Kass L, Weekes J, Carpenter L: Effect of magnesium supplementation on blood pressure: a meta-Analysis. Eur J Clin Nutr 2012;66: 411-418. 10.1038/ejcn.2012.4 22318649
51. Touyz RM, Yao G: Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 337-344. 10.1097/00004872-200302000-00025 12569264